Molnuvid 200 (Molnupiravir)

Molnuvid 200 (Molnupiravir): Overview

Molnupiravir works by introducing errors into the replication process of certain viruses. Molnuvid 200 contains 200 mg molnupiravir tablets and is an oral antiviral used for eligible adults with mild-to-moderate COVID-19 who are at increased risk of progressing to severe illness. It is a prescription treatment and should be started only when directed by a qualified healthcare professional.

Uses of Molnuvid 200 (Molnupiravir)

Molnupiravir interferes with the ability of SARS-CoV-2, the virus that causes COVID-19, to make accurate copies of its genetic material. This may reduce the amount of infectious virus in the body when treatment is begun at the appropriate stage of illness.

• Used for certain adults with mild-to-moderate COVID-19.
• Intended for people considered at higher risk of severe COVID-19 because of underlying health conditions or other risk factors.
• May be considered when an authorized or preferred alternative COVID-19 treatment is not accessible, clinically appropriate, or suitable, according to local medical guidance.
• It is not intended to prevent COVID-19 infection or replace vaccination.
• Molnupiravir is not generally used to start treatment in patients already hospitalized because of COVID-19.

How to Take Molnuvid 200 (Molnupiravir)

Take Molnuvid 200 exactly as prescribed by your doctor or pharmacist. Swallow the tablets whole with water; do not crush, chew, or break them unless a healthcare professional specifically tells you to do so. Treatment should begin as soon as possible after COVID-19 symptoms start and within the time window specified by your prescriber. Complete the prescribed course even if you begin to feel better, and ask a pharmacist what to do if you miss a dose. Do not change the amount or frequency, share the medicine, or use leftover tablets for another illness.

Strengths available

• Molnuvid 200, 40-tablet pack
• Molnuvid 200, 80-tablet pack
• Molnuvid 200, 120-tablet pack

Possible Side Effects

• Diarrhea, nausea, or vomiting
• Dizziness or headache
• Skin rash, itching, or other allergic-type reactions
• Changes in blood tests, including liver-related results

Seek urgent medical attention for swelling of the face or throat, difficulty breathing, widespread blistering rash, or other signs of a serious allergic reaction. Report troublesome or persistent symptoms to your healthcare professional.

Precautions & Warnings

• Molnupiravir is not recommended during pregnancy because it may affect fetal development. Tell your prescriber if you are pregnant, think you may be pregnant, or plan to become pregnant.
• People who could become pregnant should discuss effective contraception during treatment and for the period advised by their healthcare professional afterward.
• Men with partners who could become pregnant should follow contraception advice provided with the prescription.
• Do not breastfeed during treatment unless your clinician gives specific guidance; discuss when breastfeeding may safely resume.
• It is not authorized or recommended for children younger than 18 because it may affect bone and cartilage growth.
• Tell your doctor about liver disease, kidney disease, allergies, pregnancy plans, and every medicine or supplement you take.
• Molnupiravir does not substitute for medical assessment. Worsening breathing difficulty, chest pain, confusion, bluish lips, or severe weakness requires urgent care.

Storage

Keep Molnuvid 200 in its original container, tightly closed, and stored according to the package instructions. Protect the tablets from excess moisture and heat, keep them out of sight and reach of children, and do not use tablets after the expiration date.

Frequently Asked Questions about Molnuvid 200 (Molnupiravir)

What does the “200” mean in Molnuvid 200?

The number 200 refers to the amount of molnupiravir in each tablet: 200 mg. It describes the tablet strength, not a recommendation that a larger amount is better or appropriate for every patient. The number of tablets and treatment duration must come only from your doctor’s prescription or a pharmacist’s instructions.

Can Molnuvid 200 be used to prevent COVID-19 after exposure?

No. Molnuvid 200 is intended for certain eligible adults who already have mild-to-moderate COVID-19 and are at increased risk of severe disease. It is not a substitute for vaccination, masking advice, testing, or other public-health measures, and it should not be taken after exposure unless a healthcare professional gives a specific, evidence-based instruction.

Why must pregnancy be discussed before taking Molnuvid 200?

Molnupiravir may affect fetal development, so it is not recommended during pregnancy. Anyone who is pregnant, may be pregnant, or is planning pregnancy should speak with the prescribing clinician before treatment. Contraception and breastfeeding precautions may also apply; follow the time periods and advice provided by your healthcare professional.

Can I crush or chew Molnuvid 200 tablets?

The tablets should generally be swallowed whole with water. Do not crush, chew, or split them unless your doctor or pharmacist specifically instructs you to do so. If swallowing is difficult, contact the pharmacy or prescriber rather than changing the tablet yourself, because the product has been supplied in a particular dosage form.

What should I do if my COVID-19 symptoms worsen while using Molnuvid 200?

Contact a healthcare professional promptly if symptoms are worsening or not improving. Seek emergency help for serious breathing difficulty, persistent chest pain or pressure, new confusion, inability to stay awake, or bluish or gray lips or skin. Molnupiravir does not replace monitoring, assessment, or hospital treatment when COVID-19 becomes severe.

Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before starting any medication.